“U.S. researchers see few serious reactions to HPV vaccine” (Reuters)
“Low-dose estrogen may help if breast cancer recurs” (Reuters)
“Heart attack deaths fall after Medicare guidelines” (Reuters)“S&P: Teva Pharmaceutical Industries Ltd. Outlook Revised To Positive; ‘BBB+’ Corporate Credit, Other Ratings Affirmed” (PharmaLive.com)
“Gene Vital To Brain’s Stem Cells Implicated in Deadline Brain Cancer” (Science)
“Small-Group Education Helps Kids with Asthma” (MedPage Today)
“Low-Dose Estradiol Shows Promise For Advanced Breast Cancer” (Elsevier Global Medical News)
Low-dose estradiol shows activity against advanced breast cancer that has acquired resistance to aromatase inhibitors, “and should be further investigated,” according to a report in the Aug. 19 issue of JAMA.
This is copyright protected information, to receive the full article, please click here to sign up and register.
“Smallpox Drug Development May Get Boost From FDA” (The Pink Sheet)
FDA will discuss how animal models for smallpox and other poxvirus infections relate to these diseases in humans, during a Sept. 1-2 workshop on clinical development of therapies to treat the viruses.
This is copyright protected information, to receive the full article, please click here to sign up and register.
“J&J/DePuy’s Ceramic-On-Metal Hip Is Approvable With Conditions – Panel” (The Gray Sheet)
Johnson & Johnson/DePuy’s CoMplete ceramic-on-metal acetabular hip system should be approved by FDA, according to the agency’s Orthopedic and Rehabilitation Devices Panel.
This is copyright protected information, to receive the full article, please click here to sign up and register.
“Perrigo Plots Nutritionals Turnaround Following Record Year” (The Tan Sheet)
Turning around a nutritionals business saddled with high costs ranks as a top priority for Perrigo following record overall sales in its fiscal 2009…
This is copyright protected information, to receive the full article, please click here to sign up and register.
“BRIEF – Par Pharma says FDA accepts drug application for miconazole Lauriad” (Reuters)
“Aton Pharma Launches Expanded Distribution and Marketing for Preservative-Free TIMOPTIC in OCUDOSE” (StreetInsider.com)
“US FDA approves Extava – the first in a new portfolio in planned MS therapies from Novartis” (World Pharma News)
SUBSCRIBE